ALERT: Globe Advisor Client Management Changes
Client Center will be decommissioned December 31, 2018. Read More

CI Glob Health Sciences Cp Cl EF
  Profiles Help     Click here to print this page

Fund Sponsor: CI Investments Inc.
Portfolio Manager:
Fund Type: Open-Ended

Asset Class: Sector Equity
5-Star Rating:
RRSP Eligible: Yes

Inception Date: August, 2015
Total Assets: $2.43Million  
Sales Fee Type: No Load
Mgmt Expense Ratio (MER): 1.22%
Closed: No

Min. Invest (initial): $100,000.00
Subsequent: $5,000.00
Min. Invest (initial RRSP):
Subsequent RRSP:
Restricted: Yes
( Min. Investment $100,000)


Statistics


As of December 3, 2018

Current Price: $8.51
Daily Change $: $0.00
1 day: 0.04%
7 day: 3.29%
Month-to-Date: 0.04%
30 day: 0.12%
Year-to-Date: 13.33%

Returns as of October 31, 2018
Fund Group Avg Index*
1 month -9.47% -7.71% -6.27%
3 month -5.00% -3.83% -7.87%
6 month 5.59% 2.91% -2.28%
1 year 10.30% 6.42% -3.41%
3 year 1.50% 8.90% 6.67%
5 year n/a 13.74% 5.44%
10 year n/a 13.52% 7.56%
15 year n/a 8.22% 7.37%
20 year n/a 6.40% 7.10%
Since Inception -3.15% n/a n/a
3 year risk 16.36 13.81 7.40
3 year beta n/a n/a 1.00
* Index refers to S&P/TSX Total Return

Top Holdings as of Oct 31, 2018
Seaspine Holdings Corp Ord       5.41%
Ionis Pharmaceuticals Inc Ord       5.33%
Roche Holding AG Par       5.12%
Intercept Pharmaceuticals Inc       5.04%
Astellas Pharma Inc Ord       4.75%
Shire PLC Ord       4.15%
Alexion Pharmaceuticals Inc Ord       3.89%
Biogen Inc Ord       3.52%
Aac Holdings Inc Ord       3.42%
Glaxosmithkline PLC Ord       3.35%
Extras

Fund Report
Review and compare the current price and performance of all CI Investments Inc.

Charting
Generate different performance charts for this Mutual Fund

PDF Fund Profile
Generate a full-color, print-ready profile in PDF format for this Mutual Fund

Fund Codes & Fees
View fund code, load type, trailer fee and fee schedule data for this Mutual Fund.

Fund Price History
View a 30-day price history for this fund


Distribution Report (18 Months Up To December 3, 2018)

Frequency of Income Distributions:  None
Frequency of Capital Gain Distributions:  None

Date Income
Dividend
Capital
Gain
Total 
(Current Period)
Trailing 12-
Months Total
Reinvestment
Price
Mar 23, 2018   0.1602 0.1602 0.1602 7.737
Jun 22, 2018   0.0232 0.0232 0.1834 8.825
Sep 14, 2018   0.0232 0.0232 0.2066 8.853

Investment Objectives
This fund's objective is to obtain maximum long-term capital growth. It invests primarily in equity and equity-related securities of companies around the world that specialize in the health care or medical industry. This includes companies that provide goods and services to these companies and companies that the portfolio advisor believes would benefit from developments in the health sciences industry.

Portfolio Composition
as of Oct 31, 2018

Sector Weightings
as of Oct 31, 2018

Stock 96.18% Health Care 92.18%
Cash and Short Term Securities 3.82% Consumer Staples 2.23%
Financials 1.77%
Other sectors 0.00%

Portfolio Manager(s)